Selected research
Industry Growth & Trends
Global Major Tranquilizers Industry Growth and Trends Forecast to 2032
Market perspective
The global Major Tranquilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Major Tranquilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Major Tranquilizers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Major Tranquilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Major Tranquilizers include Johnson & Johnson, Eli Lilly, Pfizer, GSK, Bristol-Myers Squibb, AstraZeneca and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Major Tranquilizers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Major Tranquilizers market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Major Tranquilizers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Major Tranquilizers.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Major Tranquilizers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Major Tranquilizers Market by Company
Johnson & Johnson
Eli Lilly
Pfizer
GSK
Bristol-Myers Squibb
AstraZeneca
Allergan
Major Tranquilizers Segment by Type
First Generation
Third Generation
Second Generation
Major Tranquilizers Segment by Application
Bipolar Disorder
Schizophrenia
Unipolar Depression
Dementia
Others
Major Tranquilizers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Tranquilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Major Tranquilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Tranquilizers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Major Tranquilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Major Tranquilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- First Generation
- Third Generation
- Second Generation
Applications
- Bipolar Disorder
- Schizophrenia
- Unipolar Depression
- Dementia
- Others
Companies covered
- Johnson & Johnson
- Eli Lilly
- Pfizer
- GSK
- Bristol-Myers Squibb
- AstraZeneca
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Major Tranquilizers Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Major Tranquilizers Sales Estimates and Forecasts (2021-2032)
- 1.3 Major Tranquilizers Market by Type
- 1.3.1 First Generation
- 1.3.2 Third Generation
- 1.3.3 Second Generation
- 1.4 Global Major Tranquilizers Market Size by Type
- 1.4.1 Global Major Tranquilizers Market Size Overview by Type (2021-2032)
- 1.4.2 Global Major Tranquilizers Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Major Tranquilizers Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Major Tranquilizers Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Major Tranquilizers Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Major Tranquilizers Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Major Tranquilizers Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Major Tranquilizers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Major Tranquilizers Industry Trends
- 2.2 Major Tranquilizers Industry Drivers
- 2.3 Major Tranquilizers Industry Opportunities and Challenges
- 2.4 Major Tranquilizers Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Major Tranquilizers Revenue (2021-2026)
- 3.2 Global Top Players by Major Tranquilizers Sales (2021-2026)
- 3.3 Global Top Players by Major Tranquilizers Price (2021-2026)
- 3.4 Global Major Tranquilizers Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Major Tranquilizers Major Company Production Sites & Headquarters
- 3.6 Global Major Tranquilizers Company, Product Type & Application
- 3.7 Global Major Tranquilizers Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Major Tranquilizers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Major Tranquilizers Players Market Share by Revenue in 2025
- 3.8.3 2025 Major Tranquilizers Tier 1, Tier 2, and Tier 3
4 Major Tranquilizers Regional Status and Outlook
- 4.1 Global Major Tranquilizers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Major Tranquilizers Historic Market Size by Region
- 4.2.1 Global Major Tranquilizers Sales in Volume by Region (2021-2026)
- 4.2.2 Global Major Tranquilizers Sales in Value by Region (2021-2026)
- 4.2.3 Global Major Tranquilizers Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Major Tranquilizers Forecasted Market Size by Region
- 4.3.1 Global Major Tranquilizers Sales in Volume by Region (2027-2032)
- 4.3.2 Global Major Tranquilizers Sales in Value by Region (2027-2032)
- 4.3.3 Global Major Tranquilizers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Major Tranquilizers by Application
- 5.1 Major Tranquilizers Market by Application
- 5.1.1 Bipolar Disorder
- 5.1.2 Schizophrenia
- 5.1.3 Unipolar Depression
- 5.1.4 Dementia
- 5.1.5 Others
- 5.2 Global Major Tranquilizers Market Size by Application
- 5.2.1 Global Major Tranquilizers Market Size Overview by Application (2021-2032)
- 5.2.2 Global Major Tranquilizers Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Major Tranquilizers Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Major Tranquilizers Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Major Tranquilizers Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Major Tranquilizers Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Major Tranquilizers Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Major Tranquilizers Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Johnson & Johnson Major Tranquilizers Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Eli Lilly
- 6.2.1 Eli Lilly Company Information
- 6.2.2 Eli Lilly Business Overview
- 6.2.3 Eli Lilly Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Eli Lilly Major Tranquilizers Product Portfolio
- 6.2.5 Eli Lilly Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Major Tranquilizers Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 GSK
- 6.4.1 GSK Company Information
- 6.4.2 GSK Business Overview
- 6.4.3 GSK Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 GSK Major Tranquilizers Product Portfolio
- 6.4.5 GSK Recent Developments
- 6.5 Bristol-Myers Squibb
- 6.5.1 Bristol-Myers Squibb Company Information
- 6.5.2 Bristol-Myers Squibb Business Overview
- 6.5.3 Bristol-Myers Squibb Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Bristol-Myers Squibb Major Tranquilizers Product Portfolio
- 6.5.5 Bristol-Myers Squibb Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 AstraZeneca Major Tranquilizers Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Allergan
- 6.7.1 Allergan Company Information
- 6.7.2 Allergan Business Overview
- 6.7.3 Allergan Major Tranquilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Allergan Major Tranquilizers Product Portfolio
- 6.7.5 Allergan Recent Developments
7 North America by Country
- 7.1 North America Major Tranquilizers Sales by Country
- 7.1.1 North America Major Tranquilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Major Tranquilizers Sales by Country (2021-2026)
- 7.1.3 North America Major Tranquilizers Sales Forecast by Country (2027-2032)
- 7.2 North America Major Tranquilizers Market Size by Country
- 7.2.1 North America Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Major Tranquilizers Market Size by Country (2021-2026)
- 7.2.3 North America Major Tranquilizers Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Major Tranquilizers Sales by Country
- 8.1.1 Europe Major Tranquilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Major Tranquilizers Sales by Country (2021-2026)
- 8.1.3 Europe Major Tranquilizers Sales Forecast by Country (2027-2032)
- 8.2 Europe Major Tranquilizers Market Size by Country
- 8.2.1 Europe Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Major Tranquilizers Market Size by Country (2021-2026)
- 8.2.3 Europe Major Tranquilizers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Major Tranquilizers Sales by Country
- 9.1.1 Asia-Pacific Major Tranquilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Major Tranquilizers Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Major Tranquilizers Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Major Tranquilizers Market Size by Country
- 9.2.1 Asia-Pacific Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Major Tranquilizers Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Major Tranquilizers Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Major Tranquilizers Sales by Country
- 10.1.1 South America Major Tranquilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Major Tranquilizers Sales by Country (2021-2026)
- 10.1.3 South America Major Tranquilizers Sales Forecast by Country (2027-2032)
- 10.2 South America Major Tranquilizers Market Size by Country
- 10.2.1 South America Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Major Tranquilizers Market Size by Country (2021-2026)
- 10.2.3 South America Major Tranquilizers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Major Tranquilizers Sales by Country
- 11.1.1 Middle East and Africa Major Tranquilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Major Tranquilizers Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Major Tranquilizers Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Major Tranquilizers Market Size by Country
- 11.2.1 Middle East and Africa Major Tranquilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Major Tranquilizers Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Major Tranquilizers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Major Tranquilizers Value Chain Analysis
- 12.1.1 Major Tranquilizers Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Major Tranquilizers Production Mode & Process
- 12.2 Major Tranquilizers Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Major Tranquilizers Distributors
- 12.2.3 Major Tranquilizers Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst